0.012 s

- (-%)
价格区间 0.012 - 0.012   (-%)
开盘 0.012
昨收 0.012
-
买盘 -
-
卖盘 -
成交量 2
成交额 -
注释 s
测量类型 成交额
EPS (USD) -2.161
Trailing EPS (USD) 0.354
NAV (USD) 13.708
Cash In Hand (USD) 0.138
Dividend -
Dividend Yield (%) -
PE -
Trailing PE 5.08
Price / NAV 0.131
Price / Cash In Hand 13.006
Issued & Paid-up Shares 2,637,000
Treasury Shares -
Market Cap (M) 4.747
Par Value (USD) n.a.
Beta - 75 Days -2.913
R-Squared - 75 Days(%) 7.28
Beta - 500 Days 0.058
R-Squared - 500 Days(%) -
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
指数成分股
数据延迟。最后一次更新09 Sep 2021 23:37.
数据提供商
查看所有活动

关于 BIOSTAR PHARMACEUTICALS INC

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People�s Republic of China. The Company's product is the Xin Ao Xing Oleanolic Acid Capsule, an over-the- counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. As of December 31, 2011, the Company�s product line also includes five other OTC products, 10 prescription-based pharmaceuticals, five nutriceuticals or health products and one medical device. On October 25, 2011, the Company completed the acquisition of Shaanxi Weinan Huaren Pharmaceuticals, Ltd (Shaanxi Weinan).

Loading Chart...